Autologous bone marrow stem cell intralesional transplantation repairing bisphosphonate related osteonecrosis of the jaw

Head and Face Medicine

Volumn 7, Issue 1, 2011, Pages

  Cella, Luigi ^a   Oppici, Aldo ^a   Arbasi, Mariacristina ^a   Moretto, Mauro ^a   Piepoli, Massimo ^a   Vallisa, Daniele ^a   Zangrandi, Adriano ^a   Di Nunzio, Camilla ^a   Cavanna, Luigi ^a  

^a Hospital of Piacenza   (Italy)

Author keywords

Bisphoshonate; Organ repair; Osteonecrosis of the Jaw; Stem cell transplantation

Indexed keywords

BISPHOSPHONIC ACID DERIVATIVE; PAMIDRONIC ACID;

AGED; ARTICLE; AUTOTRANSPLANTATION; BONE NECROSIS; CASE REPORT; CHEMICALLY INDUCED DISORDER; FEMALE; HUMAN; INTRALESIONAL DRUG ADMINISTRATION; JAW DISEASE; POSTMENOPAUSE OSTEOPOROSIS; STEM CELL TRANSPLANTATION;

AGED; DIPHOSPHONATES; FEMALE; HUMANS; INJECTIONS, INTRALESIONAL; JAW DISEASES; OSTEONECROSIS; OSTEOPOROSIS, POSTMENOPAUSAL; STEM CELL TRANSPLANTATION; TRANSPLANTATION, AUTOLOGOUS;

EID: 80051659629     PISSN: None     EISSN: 1746160X     Source Type: Journal    
DOI: 10.1186/1746-160X-7-16     Document Type: Article

References (41)

1. McClug MR. Bisphosphonates. Endocrinol Metab Clin North Am 2003, 32. 253 71.
2. Santini D, Vespasiani Gentilucci U, Vincenzi B, Picardi A, Vasaturo F. The antineoplastic role of bisphosphonates: from basic research to clinical evidence. Ann Oncol 2003, 14:1468-76. 10.1093/annonc/mdg401, 14504045.
3. Boissier S, Magnetto S, Frappart L, Cuzin B, Ebetino FH, Delmas PD. Bisphosphonates inhibit prostate and breast carcinoma cell adhesion to unmineralized and mineralized bone extracellular matrices. Cancer Res 1997, 57:3890-3894.
4. Wysoski DK. Reports of esophageal cancer with oral bisphosphonates use. N Engl J Med 2009, 360:89-90. 10.1056/NEJMc0808738, 19118315.
5. Ibrahim T, Barbanti F, Giorgio Marrano G, Mercatali L, Ronconi S, Vicini C. Osteonecrosis of the Jaw in patients with bone matastases treated with bisphosphonates: a retrospective study. Oncologist 2008, 13:330-336. 10.1634/theoncologist.2007-0159, 18378544.
6. Bagan JV, Jimenez Y, Murillo J, Hernandez S, Poveda R, Sanchis JM. Jaw osteonecrosis associated with bisphosphonates: multiple exposed areas and its relationship to teeth extractions. Study of 20 cases. Oral oncol 2006, 42:327-329. 10.1016/j.oraloncology.2005.08.001, 16275156.
7. Hewitt C, Farah C. Bisphosphonates-related osteonecrosis of the jaws: a comprehensive review. J Oral Pathol Med 2007, 36:319-328. 10.1111/j.1600-0714.2007.00540.x, 17559492.
8. American Dental Association Council on Scientific Affairs Dental Management of patients receiving oral bisphosphonate Therapy: Expert panel recommendations. J Am Assoc 2006, 137:1144-1150. American Dental Association Council on Scientific Affairs.
9. Cavanna L, Bertè R, Arcari A, Mordenti P, Pagani R, Vallisa D. Osteonecrosis of the Jaw. A newly emerging sete-specific osseous pathology in opatients with cancer treated with bisphosphonates. Report of 5 cases and review of the literature. Eur J Internal Med 2007, 18:417-422.
10. Rizzoli R, Burlet N, Cahall D, Delmas PD, Eriksen EF, Felsenberg D. Osteonecrosis of the jaw and bisphosphonate treatment for osteoporosis. Bone 2008, 42:841-847. 10.1016/j.bone.2008.01.003, 18314405.
11. Marx RE, Sawatari Y, Fortin M, Broumand V. Bisphosphonate-induced exposed bone (osteonecrosis/osteopetrosis) of the jaws: risk factors, recognition, prevention and treatment. J Oral Maxillofac Surg 2005, 63:1567-1575. 10.1016/j.joms.2005.07.010, 16243172.
12. Yarom N, Yahalom R, Shoshani Y, Hamed W, Regev E, Elad S. Osteonecrosis of the jaw induced by orally administered bisphosphonates: incidence, clinical features, predisposing factors and teatment outcome. Osteoporos Int 2007, 18:1363-1370. 10.1007/s00198-007-0384-2, 17598065.
13. Elad S, Yarom N, Hamed W, Ayalon S, Yahalom R, Regev E. Osteomyelitis and necrosis of the jaw in patients treated with bisphosphonates A comparative study. Clin Lab Haematol 2006, 28:393-398. 10.1111/j.1365-2257.2006.00841.x, 17105493.
14. Ruggiero SL, Fantasia J, Carlson E. Bisphosphonates-related osteonecrosis of the jaw: background and guidlines for diagnosis, staging and management. Oral Surg. Oral Med Oral Path Oral Radio Endod 2006, 102:433-41.
15. Vescovi P, Merigo E, Meleti M, Fornaini C, Bonanini M, Rocca EP, De Moor RJ, Nammour S. Surgical treatment of maxillary osteonecrosis due to bisphosphonates using an Er: YAG (2940 nm) laser. Discussion of 17 clinical cases. Rev Belge Med Dent 2009, 64(2):87-95.
16. Rugani P, Stephan A, Truschnegg A, Obermayer-Pietsch B, Jakse N. Bisphosphonate - associated osteonecrosis of the jaws: surgical treatment with ErCrYSGG-laser. Case report. OOOOE 2010, 110:e1-e6.
17. Ruggiero SL, Dodson TB, Assale LA, Landesberg R, Marx RE, Mehrotra B. American Association of Oral and Maxillofacial Surgeons Position Paper on Bisphosphonate-Relate Osteonecrosis of the Jaws-2009 Update. J Oral Maxillofac Surg 2009, 67(Suppl):2-12.
18. Madrid C, Bouferrache K, Abarca M, Jaques B, Broome M. Bisphosphonate-related osteonecrosis of the jaws: how to manage cancer patients. Oral Oncology 2010, 46:468-470. 10.1016/j.oraloncology.2010.03.016, 20452814.
19. Lee JJ, Cheng SJ, Jeng JH, Ching CP, Lau HP, Kok SH. Successful treatment of advanced bisphosphonate-related osteonecrosis of the mandible with adjunctive teriparatide therapy. Wiley InterScience 2010, http://www.interscience.wiley.com
20. Wilde F, Heufelder M, Winter K, Hendricks J, Frerich B, Schramm A, Hemprich A. The role of surgical therapy in the management of intravenous bisphosphonates-related osteonecrosis of the jaw. OOOOE 2010,
21. Korbling M, Estrov Z. Adult stem cells for tissue repair--a new therapeutic concept?. N Engl J Med 2003, 349:570-582. 10.1056/NEJMra022361, 12904523.
22. Schneuder RK, Puellen A, Kramann R, Raupach K, Bornemann J, Knuechel R, Perez-Buoza A, Neuss S. The osteogenic differentiation of adult bone marrow and perinatal umbilical mesenchymal stem cells and matrix remodelling in three-dimensional collagen scaffolds. Biomaterial 2010, 31:467-480.
23. Ruggiero S, Gralow J, Marx RE, Hoff AO, Schubert MM, Huryn JM, Toth B, Damato K, Valero V. Practical guidelines for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in patients with cancer. J Oncol Prac 2006, 2:7-14.
24. Gussoni E, Soneoka Y, Strickland CD, Buzney EA, Khan MK, Flint AF, Kunkel LM, Mulligan RC. Dystrophin expression in the mdx mouse restored by stem cell transplantation. Nature 1999, 401:309-394.
25. Petersen BE, Bowen WC, Patrene KD, Mars WM, Sullivan AK, Murase N, Boggs SS, Greenberger JS, Goff JP. Bone marrow as a potential source of hepatic oval cells. Science 1999, 284:1168-1170. 10.1126/science.284.5417.1168, 10325227.
26. Piepoli M, Vallisa D, Arbasi C, Cavanna L, Cerri L, Mori M, Passerini F, Tommasi L, Rossi A, Capuccci A. Bone marrow cell transplantation improves cardiac, autonomic, and functional indexes in acute anterior myocardial infarction patients (Cardiac Study). European Journal of Heart Failure
27. Marx RE. Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaw: a growing epidemic. J Oral Maxillofac Surg 2003, 61:1115-1117. 10.1016/S0278-2391(03)00720-1, 12966493.
28. Wang J, Goodger NM, Pogrel MA. Osteonecrosis of the jawsmassociated with cancer chemotherapy. J Oral Maxillofac Surg 2003, 61:1104-1107. 10.1016/S0278-2391(03)00328-8, 12966490.
29. Edwards BJ, Gounder M, McKoy JM, Boyd I, Farrugia M, Migliorati C, Marx R, Ruggiaero S, Dimopoulos M, Raisch DW, Singhal S, Carson K, Obadina E, Trifilio S, West D, Mehta J, Bennett CL. Bisphosphonate use and osteonecrosis of the jaw: Pharmacovigilance and reporting of this serious adverse event. Lancet Oncol 2008, 9:1166. 10.1016/S1470-2045(08)70305-X, 19038763.
30. Salamon A, Toldy E. Use of mesenchymal stem cells from adult bone marrow for injured tissue repair. Orv Hetil 2009, 150(27):1259-1265. 10.1556/OH.2009.28666, 19531459.
31. Connolly J, Grese R, Lipello L, Dehne R. Development of an osteogenic bone marrow preparation. J Bone Joint Surg 1989, 71A:684-691.
32. Muschler G, Boehm C, Easley K. Aspiration to obtain osteoblast progenitor cells from human bone marrow: the influence of aspiration volume. J Bone Joint Surg 1997, 79A:1699-1707.
33. Usami K, Mizuno H, Okada K, Narita Y, Aoki M, Kondo T, Mizuno D, Mase J, Nishiguchi H, Kagami H, Minoru U. Composite implantation of mesenchymal stem cells with endothelial progenitor cells enhances tissue-engineered bone formation. J Biomed Mater Res A 2009, 90(3):730-41.
34. Bittira B, Shum-Tim D, Al-Khaldi A, Chiu RC. Mobilization and homing of bone marrow stromal cells in Myocardial infarction. Eur J Cardiotoracic Surg 2003, 24:393-398.
35. Prockop DJ. Marrow stromal cells as stem cells for nonhematopoietic tissues. Science 1997, 276:71-74. 10.1126/science.276.5309.71, 9082988.
36. Asahara T, Takahashi T, Masuda H, Kalka C, Chen D, Iwaguro H, Inai Y, Silver M, Isner JM. VEGF contributes to postnatal neovascularization by mobilizing bone marrow-derived endothelial progenitor cells. EMBO J 1999, 18:3964-3972. 10.1093/emboj/18.14.3964, 1171472, 10406801.
37. Orlic D, Kajstura J, Chimenti S, Bodine DM, Leri A, Anversa P. Bone marrow cells regenerate infracted myocardium. Nature 2001, 410:701-705. 10.1038/35070587, 11287958.
38. Smart N, Riley PR. The stem cell movement. Circ Res 2008, 102. 1155 1168.
39. Sun J, Li SH, Liu SM, Wu J, Weisel RD, Zhuo YF, Yau TM, Li R, Fazel SS. Improvement in cardiac function after bone marrow cell therapy is associated with an increase in myocardial inflammation. Am J Physiol Heart Circ Physiol 2009, 296:H43-H50.
40. Kikuiri T, Kin I, Yamaza T, Akiyama K, Zhang Q, Li Y, Chen C, Chen C, Wang S, le AD, Shi S. Cell-based immunotherapy with mesenchymal stem cells cures bisphosphonate-related osteonecrosis of the jaw - like disease in mice. J Bone Miner Res 2010, 25(7):1668-79. 10.1002/jbmr.37, 3154005, 20200952.
41. Handschel J, Meyer U. Infection, vascularization, remodelling - are stem cell the answers for bone disease of the jaw?. Head & Face Medicine 2011, 7:5. 10.1186/1746-160X-7-5, 21866574.